Proceedings of the National Academy of Sciences · 2008 · 182 citations · 26 references
MedicineMolecular BiologyOncologyCarcinogenesisMolecular OncologySignal TransductionBiomarkers In Urologic OncologyOncogenic Signaling PathwaysProstate CancerProstate PathologyProstatic PathologySignal Transduction In CancerCancer Cell Line ModelsConditional Gene KnockoutDouble Knockout ModelsHomozygous DeletionProstate AdenocarcinomaProstate CarcinogenesisPten InactivationPten Signaling
GRP78/BiP has recently emerged as a novel biomarker for aggressive prostate cancer. Here, we report that homozygous deletion of Grp78 specifically in mouse prostate epithelium suppresses prostate tumorigenesis without affecting postnatal prostate development and growth. Mouse prostates with double conditional knockout of Grp78 and Pten exhibit normal histology and cytology, in contrast to the invasive adenocarcinoma in mouse prostates with Pten inactivation. AKT activation in Pten null prostate epithelium is inhibited by Grp78 homozygous deletion, corresponding with suppression of AKT phosphorylation by GRP78 knockdown in prostate cancer cell line. Thus, inactivation of GRP78 may represent a previously undescribed approach to stop prostate cancer and potentially other cancers resulting from the loss of PTEN tumor suppression and/or activation of the oncogenic AKT.
26
Shunyou Wang, Jing Gao, Qun‐Ying Lei et al. · Cancer Cell · 2003 · 1.1K citations · Full text
Tenets of PTEN Tumor Suppression
Leonardo Salmena, Arkaitz Carracedo, Pier Paolo Pandolfi · Cell · 2008 · 1K citations · Full text
Medicine, Cancer Biology, Oncology +12
Aging Hematopoietic Stem Cells Decline in Function and Exhibit Epigenetic Dysregulation
Stuart M. Chambers, Chad A. Shaw, Catherine E. Gatza et al. · PLoS Biology · 2007 · 796 citations · Full text
Education, Cell Biology, Genetics +17